1 Introduction to Research & Analysis Reports
1.1 Bacillus Calmette Guerin Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Bacillus Calmette Guerin Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Bacillus Calmette Guerin Vaccine Overall Market Size
2.1 Global Bacillus Calmette Guerin Vaccine Market Size: 2022 VS 2029
2.2 Global Bacillus Calmette Guerin Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Bacillus Calmette Guerin Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top Bacillus Calmette Guerin Vaccine Players in Global Market
3.2 Top Global Bacillus Calmette Guerin Vaccine Companies Ranked by Revenue
3.3 Global Bacillus Calmette Guerin Vaccine Revenue by Companies
3.4 Global Bacillus Calmette Guerin Vaccine Sales by Companies
3.5 Global Bacillus Calmette Guerin Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Bacillus Calmette Guerin Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Bacillus Calmette Guerin Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Bacillus Calmette Guerin Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Bacillus Calmette Guerin Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Bacillus Calmette Guerin Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Bacillus Calmette Guerin Vaccine Market Size Markets, 2022 & 2029
4.1.2 Immune Type
4.1.3 Therapy Type
4.2 By Type – Global Bacillus Calmette Guerin Vaccine Revenue & Forecasts
4.2.1 By Type – Global Bacillus Calmette Guerin Vaccine Revenue, 2018-2023
4.2.2 By Type – Global Bacillus Calmette Guerin Vaccine Revenue, 2024-2029
4.2.3 By Type – Global Bacillus Calmette Guerin Vaccine Revenue Market Share, 2018-2029
4.3 By Type – Global Bacillus Calmette Guerin Vaccine Sales & Forecasts
4.3.1 By Type – Global Bacillus Calmette Guerin Vaccine Sales, 2018-2023
4.3.2 By Type – Global Bacillus Calmette Guerin Vaccine Sales, 2024-2029
4.3.3 By Type – Global Bacillus Calmette Guerin Vaccine Sales Market Share, 2018-2029
4.4 By Type – Global Bacillus Calmette Guerin Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Bacillus Calmette Guerin Vaccine Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application – Global Bacillus Calmette Guerin Vaccine Revenue & Forecasts
5.2.1 By Application – Global Bacillus Calmette Guerin Vaccine Revenue, 2018-2023
5.2.2 By Application – Global Bacillus Calmette Guerin Vaccine Revenue, 2024-2029
5.2.3 By Application – Global Bacillus Calmette Guerin Vaccine Revenue Market Share, 2018-2029
5.3 By Application – Global Bacillus Calmette Guerin Vaccine Sales & Forecasts
5.3.1 By Application – Global Bacillus Calmette Guerin Vaccine Sales, 2018-2023
5.3.2 By Application – Global Bacillus Calmette Guerin Vaccine Sales, 2024-2029
5.3.3 By Application – Global Bacillus Calmette Guerin Vaccine Sales Market Share, 2018-2029
5.4 By Application – Global Bacillus Calmette Guerin Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Bacillus Calmette Guerin Vaccine Market Size, 2022 & 2029
6.2 By Region – Global Bacillus Calmette Guerin Vaccine Revenue & Forecasts
6.2.1 By Region – Global Bacillus Calmette Guerin Vaccine Revenue, 2018-2023
6.2.2 By Region – Global Bacillus Calmette Guerin Vaccine Revenue, 2024-2029
6.2.3 By Region – Global Bacillus Calmette Guerin Vaccine Revenue Market Share, 2018-2029
6.3 By Region – Global Bacillus Calmette Guerin Vaccine Sales & Forecasts
6.3.1 By Region – Global Bacillus Calmette Guerin Vaccine Sales, 2018-2023
6.3.2 By Region – Global Bacillus Calmette Guerin Vaccine Sales, 2024-2029
6.3.3 By Region – Global Bacillus Calmette Guerin Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Bacillus Calmette Guerin Vaccine Revenue, 2018-2029
6.4.2 By Country – North America Bacillus Calmette Guerin Vaccine Sales, 2018-2029
6.4.3 US Bacillus Calmette Guerin Vaccine Market Size, 2018-2029
6.4.4 Canada Bacillus Calmette Guerin Vaccine Market Size, 2018-2029
6.4.5 Mexico Bacillus Calmette Guerin Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Bacillus Calmette Guerin Vaccine Revenue, 2018-2029
6.5.2 By Country – Europe Bacillus Calmette Guerin Vaccine Sales, 2018-2029
6.5.3 Germany Bacillus Calmette Guerin Vaccine Market Size, 2018-2029
6.5.4 France Bacillus Calmette Guerin Vaccine Market Size, 2018-2029
6.5.5 U.K. Bacillus Calmette Guerin Vaccine Market Size, 2018-2029
6.5.6 Italy Bacillus Calmette Guerin Vaccine Market Size, 2018-2029
6.5.7 Russia Bacillus Calmette Guerin Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries Bacillus Calmette Guerin Vaccine Market Size, 2018-2029
6.5.9 Benelux Bacillus Calmette Guerin Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Bacillus Calmette Guerin Vaccine Revenue, 2018-2029
6.6.2 By Region – Asia Bacillus Calmette Guerin Vaccine Sales, 2018-2029
6.6.3 China Bacillus Calmette Guerin Vaccine Market Size, 2018-2029
6.6.4 Japan Bacillus Calmette Guerin Vaccine Market Size, 2018-2029
6.6.5 South Korea Bacillus Calmette Guerin Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia Bacillus Calmette Guerin Vaccine Market Size, 2018-2029
6.6.7 India Bacillus Calmette Guerin Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Bacillus Calmette Guerin Vaccine Revenue, 2018-2029
6.7.2 By Country – South America Bacillus Calmette Guerin Vaccine Sales, 2018-2029
6.7.3 Brazil Bacillus Calmette Guerin Vaccine Market Size, 2018-2029
6.7.4 Argentina Bacillus Calmette Guerin Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Bacillus Calmette Guerin Vaccine Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Bacillus Calmette Guerin Vaccine Sales, 2018-2029
6.8.3 Turkey Bacillus Calmette Guerin Vaccine Market Size, 2018-2029
6.8.4 Israel Bacillus Calmette Guerin Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia Bacillus Calmette Guerin Vaccine Market Size, 2018-2029
6.8.6 UAE Bacillus Calmette Guerin Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck Bacillus Calmette Guerin Vaccine Major Product Offerings
7.1.4 Merck Bacillus Calmette Guerin Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 Merck Key News & Latest Developments
7.2 Sanofi Pasteur
7.2.1 Sanofi Pasteur Company Summary
7.2.2 Sanofi Pasteur Business Overview
7.2.3 Sanofi Pasteur Bacillus Calmette Guerin Vaccine Major Product Offerings
7.2.4 Sanofi Pasteur Bacillus Calmette Guerin Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 Sanofi Pasteur Key News & Latest Developments
7.3 Japan BCG Lab
7.3.1 Japan BCG Lab Company Summary
7.3.2 Japan BCG Lab Business Overview
7.3.3 Japan BCG Lab Bacillus Calmette Guerin Vaccine Major Product Offerings
7.3.4 Japan BCG Lab Bacillus Calmette Guerin Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 Japan BCG Lab Key News & Latest Developments
7.4 China National Biotec
7.4.1 China National Biotec Company Summary
7.4.2 China National Biotec Business Overview
7.4.3 China National Biotec Bacillus Calmette Guerin Vaccine Major Product Offerings
7.4.4 China National Biotec Bacillus Calmette Guerin Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 China National Biotec Key News & Latest Developments
7.5 AJ Vaccines
7.5.1 AJ Vaccines Company Summary
7.5.2 AJ Vaccines Business Overview
7.5.3 AJ Vaccines Bacillus Calmette Guerin Vaccine Major Product Offerings
7.5.4 AJ Vaccines Bacillus Calmette Guerin Vaccine Sales and Revenue in Global (2018-2023)
7.5.5 AJ Vaccines Key News & Latest Developments
7.6 Serum Institute of India
7.6.1 Serum Institute of India Company Summary
7.6.2 Serum Institute of India Business Overview
7.6.3 Serum Institute of India Bacillus Calmette Guerin Vaccine Major Product Offerings
7.6.4 Serum Institute of India Bacillus Calmette Guerin Vaccine Sales and Revenue in Global (2018-2023)
7.6.5 Serum Institute of India Key News & Latest Developments
7.7 Intervax
7.7.1 Intervax Company Summary
7.7.2 Intervax Business Overview
7.7.3 Intervax Bacillus Calmette Guerin Vaccine Major Product Offerings
7.7.4 Intervax Bacillus Calmette Guerin Vaccine Sales and Revenue in Global (2018-2023)
7.7.5 Intervax Key News & Latest Developments
7.8 GSBPL
7.8.1 GSBPL Company Summary
7.8.2 GSBPL Business Overview
7.8.3 GSBPL Bacillus Calmette Guerin Vaccine Major Product Offerings
7.8.4 GSBPL Bacillus Calmette Guerin Vaccine Sales and Revenue in Global (2018-2023)
7.8.5 GSBPL Key News & Latest Developments
7.9 Statens Serum Institute
7.9.1 Statens Serum Institute Company Summary
7.9.2 Statens Serum Institute Business Overview
7.9.3 Statens Serum Institute Bacillus Calmette Guerin Vaccine Major Product Offerings
7.9.4 Statens Serum Institute Bacillus Calmette Guerin Vaccine Sales and Revenue in Global (2018-2023)
7.9.5 Statens Serum Institute Key News & Latest Developments
7.10 Biomed Lublin
7.10.1 Biomed Lublin Company Summary
7.10.2 Biomed Lublin Business Overview
7.10.3 Biomed Lublin Bacillus Calmette Guerin Vaccine Major Product Offerings
7.10.4 Biomed Lublin Bacillus Calmette Guerin Vaccine Sales and Revenue in Global (2018-2023)
7.10.5 Biomed Lublin Key News & Latest Developments
7.11 ANLIS Malbran
7.11.1 ANLIS Malbran Company Summary
7.11.2 ANLIS Malbran Bacillus Calmette Guerin Vaccine Business Overview
7.11.3 ANLIS Malbran Bacillus Calmette Guerin Vaccine Major Product Offerings
7.11.4 ANLIS Malbran Bacillus Calmette Guerin Vaccine Sales and Revenue in Global (2018-2023)
7.11.5 ANLIS Malbran Key News & Latest Developments
7.12 Fundação Ataulpho de Paiva
7.12.1 Fundação Ataulpho de Paiva Company Summary
7.12.2 Fundação Ataulpho de Paiva Bacillus Calmette Guerin Vaccine Business Overview
7.12.3 Fundação Ataulpho de Paiva Bacillus Calmette Guerin Vaccine Major Product Offerings
7.12.4 Fundação Ataulpho de Paiva Bacillus Calmette Guerin Vaccine Sales and Revenue in Global (2018-2023)
7.12.5 Fundação Ataulpho de Paiva Key News & Latest Developments
7.13 BB-NCIPD
7.13.1 BB-NCIPD Company Summary
7.13.2 BB-NCIPD Bacillus Calmette Guerin Vaccine Business Overview
7.13.3 BB-NCIPD Bacillus Calmette Guerin Vaccine Major Product Offerings
7.13.4 BB-NCIPD Bacillus Calmette Guerin Vaccine Sales and Revenue in Global (2018-2023)
7.13.5 BB-NCIPD Key News & Latest Developments
7.14 Taj Pharmaceuticals
7.14.1 Taj Pharmaceuticals Company Summary
7.14.2 Taj Pharmaceuticals Business Overview
7.14.3 Taj Pharmaceuticals Bacillus Calmette Guerin Vaccine Major Product Offerings
7.14.4 Taj Pharmaceuticals Bacillus Calmette Guerin Vaccine Sales and Revenue in Global (2018-2023)
7.14.5 Taj Pharmaceuticals Key News & Latest Developments
7.15 Bio Farma
7.15.1 Bio Farma Company Summary
7.15.2 Bio Farma Business Overview
7.15.3 Bio Farma Bacillus Calmette Guerin Vaccine Major Product Offerings
7.15.4 Bio Farma Bacillus Calmette Guerin Vaccine Sales and Revenue in Global (2018-2023)
7.15.5 Bio Farma Key News & Latest Developments
7.16 Microgen
7.16.1 Microgen Company Summary
7.16.2 Microgen Business Overview
7.16.3 Microgen Bacillus Calmette Guerin Vaccine Major Product Offerings
7.16.4 Microgen Bacillus Calmette Guerin Vaccine Sales and Revenue in Global (2018-2023)
7.16.5 Microgen Key News & Latest Developments
7.17 Torlakinstitut
7.17.1 Torlakinstitut Company Summary
7.17.2 Torlakinstitut Business Overview
7.17.3 Torlakinstitut Bacillus Calmette Guerin Vaccine Major Product Offerings
7.17.4 Torlakinstitut Bacillus Calmette Guerin Vaccine Sales and Revenue in Global (2018-2023)
7.17.5 Torlakinstitut Key News & Latest Developments
7.18 Institut Pasteur de Tunis
7.18.1 Institut Pasteur de Tunis Company Summary
7.18.2 Institut Pasteur de Tunis Business Overview
7.18.3 Institut Pasteur de Tunis Bacillus Calmette Guerin Vaccine Major Product Offerings
7.18.4 Institut Pasteur de Tunis Bacillus Calmette Guerin Vaccine Sales and Revenue in Global (2018-2023)
7.18.5 Institut Pasteur de Tunis Key News & Latest Developments
7.19 IVAC
7.19.1 IVAC Company Summary
7.19.2 IVAC Business Overview
7.19.3 IVAC Bacillus Calmette Guerin Vaccine Major Product Offerings
7.19.4 IVAC Bacillus Calmette Guerin Vaccine Sales and Revenue in Global (2018-2023)
7.19.5 IVAC Key News & Latest Developments
8 Global Bacillus Calmette Guerin Vaccine Production Capacity, Analysis
8.1 Global Bacillus Calmette Guerin Vaccine Production Capacity, 2018-2029
8.2 Bacillus Calmette Guerin Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Bacillus Calmette Guerin Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Bacillus Calmette Guerin Vaccine Supply Chain Analysis
10.1 Bacillus Calmette Guerin Vaccine Industry Value Chain
10.2 Bacillus Calmette Guerin Vaccine Upstream Market
10.3 Bacillus Calmette Guerin Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Bacillus Calmette Guerin Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
世界のカルメット菌ゲリン菌ワクチン市場予測2023-2029：免疫用、治療用 |
| 【英語タイトル】Bacillus Calmette Guerin Vaccine Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU5706 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：111 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：医薬品＆医療 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥494,000 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥642,200 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥741,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界のカルメット菌ゲリン菌ワクチン市場規模と予測を収録しています。・世界のカルメット菌ゲリン菌ワクチン市場：売上、2018年-2023年、2024年-2029年 ・世界のカルメット菌ゲリン菌ワクチン市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のカルメット菌ゲリン菌ワクチン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「免疫用」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 カルメット菌ゲリン菌ワクチンのグローバル主要企業は、Merck、 Sanofi Pasteur、 Japan BCG Lab、 China National Biotec、 AJ Vaccines、 Serum Institute of India、 Intervax、 GSBPL、 Statens Serum Institute、 Biomed Lublin、 ANLIS Malbran、 Fundação Ataulpho de Paiva、 BB-NCIPD、 Taj Pharmaceuticals、 Bio Farma、 Microgen、 Torlakinstitut、 Institut Pasteur de Tunis、 IVACなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、カルメット菌ゲリン菌ワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のカルメット菌ゲリン菌ワクチン市場：タイプ別、2018年-2023年、2024年-2029年 世界のカルメット菌ゲリン菌ワクチン市場：タイプ別市場シェア、2022年 ・免疫用、治療用 世界のカルメット菌ゲリン菌ワクチン市場：用途別、2018年-2023年、2024年-2029年 世界のカルメット菌ゲリン菌ワクチン市場：用途別市場シェア、2022年 ・病院、診療所、その他 世界のカルメット菌ゲリン菌ワクチン市場：地域・国別、2018年-2023年、2024年-2029年 世界のカルメット菌ゲリン菌ワクチン市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるカルメット菌ゲリン菌ワクチンのグローバル売上、2018年-2023年 ・主要企業におけるカルメット菌ゲリン菌ワクチンのグローバル売上シェア、2022年 ・主要企業におけるカルメット菌ゲリン菌ワクチンのグローバル販売量、2018年-2023年 ・主要企業におけるカルメット菌ゲリン菌ワクチンのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Merck、 Sanofi Pasteur、 Japan BCG Lab、 China National Biotec、 AJ Vaccines、 Serum Institute of India、 Intervax、 GSBPL、 Statens Serum Institute、 Biomed Lublin、 ANLIS Malbran、 Fundação Ataulpho de Paiva、 BB-NCIPD、 Taj Pharmaceuticals、 Bio Farma、 Microgen、 Torlakinstitut、 Institut Pasteur de Tunis、 IVAC ************************************************************* ・調査・分析レポートの概要 カルメット菌ゲリン菌ワクチン市場の定義 市場セグメント 世界のカルメット菌ゲリン菌ワクチン市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のカルメット菌ゲリン菌ワクチン市場規模 世界のカルメット菌ゲリン菌ワクチン市場規模：2022年 VS 2029年 世界のカルメット菌ゲリン菌ワクチン市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのカルメット菌ゲリン菌ワクチンの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のカルメット菌ゲリン菌ワクチン製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：免疫用、治療用 カルメット菌ゲリン菌ワクチンのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、診療所、その他 カルメット菌ゲリン菌ワクチンの用途別グローバル売上・予測 ・地域別市場分析 地域別カルメット菌ゲリン菌ワクチン市場規模 2022年と2029年 地域別カルメット菌ゲリン菌ワクチン売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Merck、 Sanofi Pasteur、 Japan BCG Lab、 China National Biotec、 AJ Vaccines、 Serum Institute of India、 Intervax、 GSBPL、 Statens Serum Institute、 Biomed Lublin、 ANLIS Malbran、 Fundação Ataulpho de Paiva、 BB-NCIPD、 Taj Pharmaceuticals、 Bio Farma、 Microgen、 Torlakinstitut、 Institut Pasteur de Tunis、 IVAC ... |
Bacillus Calmette Guerin Vaccine provides immunity or protection against tuberculosis (TB). The vaccine may be given to persons at high risk of developing TB.
This report aims to provide a comprehensive presentation of the global market for Bacillus Calmette Guerin Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bacillus Calmette Guerin Vaccine. This report contains market size and forecasts of Bacillus Calmette Guerin Vaccine in global, including the following market information:
Global Bacillus Calmette Guerin Vaccine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Bacillus Calmette Guerin Vaccine Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Bacillus Calmette Guerin Vaccine companies in 2022 (%)
The global Bacillus Calmette Guerin Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Immune Type Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Bacillus Calmette Guerin Vaccine include Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, AJ Vaccines, Serum Institute of India, Intervax, GSBPL and Statens Serum Institute, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bacillus Calmette Guerin Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bacillus Calmette Guerin Vaccine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Bacillus Calmette Guerin Vaccine Market Segment Percentages, by Type, 2022 (%)
Immune Type
Therapy Type
Global Bacillus Calmette Guerin Vaccine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Bacillus Calmette Guerin Vaccine Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Others
Global Bacillus Calmette Guerin Vaccine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Bacillus Calmette Guerin Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Bacillus Calmette Guerin Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Bacillus Calmette Guerin Vaccine revenues share in global market, 2022 (%)
Key companies Bacillus Calmette Guerin Vaccine sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Bacillus Calmette Guerin Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
AJ Vaccines
Serum Institute of India
Intervax
GSBPL
Statens Serum Institute
Biomed Lublin
ANLIS Malbran
Fundação Ataulpho de Paiva
BB-NCIPD
Taj Pharmaceuticals
Bio Farma
Microgen
Torlakinstitut
Institut Pasteur de Tunis
IVAC
Outline of Major Chapters:
Chapter 1: Introduces the definition of Bacillus Calmette Guerin Vaccine, market overview.
Chapter 2: Global Bacillus Calmette Guerin Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Bacillus Calmette Guerin Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Bacillus Calmette Guerin Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Bacillus Calmette Guerin Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
❖ レポートの目次 ❖
| ★調査レポート[世界のカルメット菌ゲリン菌ワクチン市場予測2023-2029：免疫用、治療用] (コード：MMG23JU5706)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界のカルメット菌ゲリン菌ワクチン市場予測2023-2029：免疫用、治療用]についてメールでお問い合わせ |
